Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023803521> ?p ?o ?g. }
- W2023803521 endingPage "539" @default.
- W2023803521 startingPage "531" @default.
- W2023803521 abstract "Background CD4+CD25+FOXP3+ regulatory T cells (Tregs) are thought to induce immunotolerance in melanoma. They have not yet been investigated in the entire spectrum of melanocytic cutaneous lesions within a tumour site. Objectives To evaluate CD4+CD25+FOXP3+ Tregs among tumour-infiltrating lymphocytes in cutaneous melanocytic lesions. Methods We analysed 128 lesions (10 benign junctional common naevi, 10 benign compound common naevi, 10 compound Spitz naevi, 10 junctional atypical naevi, 20 compound atypical naevi, 20 radial growth phase melanomas, 30 vertical growth phase melanomas and 18 melanoma metastases). Tregs were identified by CD25-FOXP3 double immunostains. Results This study indicates that CD4+/CD25+FOXP3+ Tregs are present in all groups of lesions. Junctional atypical naevi, compound atypical naevi and radial growth phase melanomas showed the highest percentages of CD4+CD25+FOXP3+ Tregs (junctional atypical naevi vs. junctional common naevi, compound common naevi, compound Spitz naevi, melanoma metastases: P < 0·0001; junctional atypical naevi vs. vertical growth phase melanomas: P = 0·001; compound atypical naevi vs. junctional common naevi, compound common naevi: P < 0·0001; compound atypical naevi vs. compound Spitz naevi, melanoma metastases: P = 0·002; compound atypical naevi vs. vertical growth phase melanomas: P = 0·02; radial growth phase melanomas vs. junctional common naevi, compound common naevi, compound Spitz naevi, melanoma metastases: P < 0·0001; radial growth phase melanomas vs. vertical growth phase melanomas: P = 0·008). Conclusions The strong prevalence of CD25+FOXP3+ Tregs both in junctional andcompound atypical naevi and radial growth phase melanomas, suggests that they induce immunotolerance early during melanoma genesis, favouring melanoma growth. Their evaluation within a tumour site could be useful for prognostic and therapeutic purposes." @default.
- W2023803521 created "2016-06-24" @default.
- W2023803521 creator A5001125713 @default.
- W2023803521 creator A5003574455 @default.
- W2023803521 creator A5016847852 @default.
- W2023803521 creator A5049110103 @default.
- W2023803521 creator A5071612095 @default.
- W2023803521 creator A5073090447 @default.
- W2023803521 creator A5075131381 @default.
- W2023803521 creator A5081501587 @default.
- W2023803521 creator A5090778945 @default.
- W2023803521 date "2007-09-01" @default.
- W2023803521 modified "2023-09-23" @default.
- W2023803521 title "Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases" @default.
- W2023803521 cites W128474149 @default.
- W2023803521 cites W1592596551 @default.
- W2023803521 cites W1967306689 @default.
- W2023803521 cites W1984677655 @default.
- W2023803521 cites W1984909066 @default.
- W2023803521 cites W1999912819 @default.
- W2023803521 cites W2002726823 @default.
- W2023803521 cites W2004708987 @default.
- W2023803521 cites W2010281909 @default.
- W2023803521 cites W2039198873 @default.
- W2023803521 cites W2050458717 @default.
- W2023803521 cites W2053261820 @default.
- W2023803521 cites W2063424635 @default.
- W2023803521 cites W2069565578 @default.
- W2023803521 cites W2075792466 @default.
- W2023803521 cites W2078197336 @default.
- W2023803521 cites W2084579140 @default.
- W2023803521 cites W2085257327 @default.
- W2023803521 cites W2096625946 @default.
- W2023803521 cites W2097811455 @default.
- W2023803521 cites W2098983864 @default.
- W2023803521 cites W2105459360 @default.
- W2023803521 cites W2106511557 @default.
- W2023803521 cites W2110313965 @default.
- W2023803521 cites W2115278843 @default.
- W2023803521 cites W2120459807 @default.
- W2023803521 cites W2121566625 @default.
- W2023803521 cites W2123149440 @default.
- W2023803521 cites W2127746314 @default.
- W2023803521 cites W2131774025 @default.
- W2023803521 cites W2132143019 @default.
- W2023803521 cites W2134054181 @default.
- W2023803521 cites W2139186046 @default.
- W2023803521 cites W2139276825 @default.
- W2023803521 cites W2141785549 @default.
- W2023803521 cites W2144350507 @default.
- W2023803521 cites W2149759831 @default.
- W2023803521 cites W2150627675 @default.
- W2023803521 cites W2151151763 @default.
- W2023803521 cites W2155094665 @default.
- W2023803521 cites W2157620815 @default.
- W2023803521 cites W2158092720 @default.
- W2023803521 cites W2158485667 @default.
- W2023803521 cites W2158606911 @default.
- W2023803521 cites W2162666968 @default.
- W2023803521 cites W2162744515 @default.
- W2023803521 cites W2166798619 @default.
- W2023803521 cites W280395377 @default.
- W2023803521 doi "https://doi.org/10.1111/j.1365-2133.2007.08057.x" @default.
- W2023803521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17596146" @default.
- W2023803521 hasPublicationYear "2007" @default.
- W2023803521 type Work @default.
- W2023803521 sameAs 2023803521 @default.
- W2023803521 citedByCount "54" @default.
- W2023803521 countsByYear W20238035212012 @default.
- W2023803521 countsByYear W20238035212014 @default.
- W2023803521 countsByYear W20238035212015 @default.
- W2023803521 countsByYear W20238035212016 @default.
- W2023803521 countsByYear W20238035212017 @default.
- W2023803521 countsByYear W20238035212018 @default.
- W2023803521 countsByYear W20238035212019 @default.
- W2023803521 countsByYear W20238035212020 @default.
- W2023803521 countsByYear W20238035212021 @default.
- W2023803521 countsByYear W20238035212022 @default.
- W2023803521 crossrefType "journal-article" @default.
- W2023803521 hasAuthorship W2023803521A5001125713 @default.
- W2023803521 hasAuthorship W2023803521A5003574455 @default.
- W2023803521 hasAuthorship W2023803521A5016847852 @default.
- W2023803521 hasAuthorship W2023803521A5049110103 @default.
- W2023803521 hasAuthorship W2023803521A5071612095 @default.
- W2023803521 hasAuthorship W2023803521A5073090447 @default.
- W2023803521 hasAuthorship W2023803521A5075131381 @default.
- W2023803521 hasAuthorship W2023803521A5081501587 @default.
- W2023803521 hasAuthorship W2023803521A5090778945 @default.
- W2023803521 hasConcept C142724271 @default.
- W2023803521 hasConcept C16005928 @default.
- W2023803521 hasConcept C203014093 @default.
- W2023803521 hasConcept C2777658100 @default.
- W2023803521 hasConcept C2779323059 @default.
- W2023803521 hasConcept C2779727006 @default.
- W2023803521 hasConcept C2780667408 @default.
- W2023803521 hasConcept C502942594 @default.
- W2023803521 hasConcept C71924100 @default.
- W2023803521 hasConcept C8891405 @default.